Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial.
CONCLUSIONS: Data from this diabetes subgroup analysis suggest that fixed combination of perindopril 10 mg/indapamide 2.5 mg should be routinely considered for the treatment of hypertension in diabetic patients who are unsuccessfully managed with other antihypertensive medications.
PMID: 24554346 [PubMed - as supplied by publisher]
Source: Advances in Therapy - Category: Drugs & Pharmacology Authors: Farsang C Tags: Adv Ther Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Environmental Health | Heart | Hydrochlorothiazide | Hypertension | Indapamide | Laboratory Medicine | Study